Insmed Incorporated (INSM) shares fell 4.9% to $108.59 as of October 1, 2026, a moderate decline from the prior close of $114.14. BestStocks flagged the session as a major change for INSM. Below, we break down what changed for INSM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
INSM fell 4.9% to $108.59
Insmed shares fell 2.80% to $110.95 amid a combination of recent analyst price-target cuts—notably Barclays lowering its target from $237 to $207 while maintaining an Overweight rating—alongside broader profit-taking in the biotech sector and cooling short-term sentiment on high-multiple rare-disease names. Volume of 989k shares (0.82x average at this time of day) remains ordinary. INSM earnings on October 29, 2026 (consensus EPS estimate −$0.39); closely monitor Barclays' and peers' positioning on pipeline programs (Brinsupri, Arikayce) and any institutional flow changes.
This summary describes the catalyst and move as first detected on Oct 1, 2026, 1:12 PM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
For Insmed Incorporated investors, the recent signals add up to a bearish shift. Weighing against that: Material negative event; Negative session, down 4.9%. Wall Street's consensus price target sits at $197.00, implying +81.4% upside from $108.59. BestStocks rates the overall signal quality low (56/100). With earnings roughly 28 days out, the next report is the most likely near-term test of the move.
INSM price reaction
INSM last traded at $108.59, down $5.55 (-4.86%) from the previous close of $114.14. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $108.59 and $129.41, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Insmed Incorporated (INSM)
▼Latest catalyst·a bearish counterpoint
The latest catalyst — a materially negative development — a bearish counterpoint that challenges the prevailing bullish analyst view.
The consensus analyst price target on Insmed Incorporated (INSM) is $197.00, 81.4% above the recent $108.59. Over the past 90 days analysts logged 0 upgrades, 9 maintains, and 0 downgrades. Here is how the bullish and bearish cases on INSM line up.
▲ The bullish case
+Wall Street's consensus price target of $197.00 implies +81.4% upside from $108.59.
+The Street's most bullish target is $235.00 (+116.4%).
▼ The bearish case
−Material negative event.
−Negative session, down 4.9%.
−Insmed Incorporated (INSM) moved -5.60% from $115.61 to $109.14 on 2026-07-13.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 1, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
INSM moved -3.32% from its $121.87 open to a $117.83 close on 2026-09-25.
Material / Earnings2026-09-22-0.1%
INSM moved -100.00% from its $121.00 open to a $120.82 close on 2026-09-22.
Material / Earnings2026-09-18-3.2%
Insmed Incorporated (INSM) moved -2.94% from $123.64 to $120.00 on 2026-09-18. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.8x the 5-day average, indicating modest institutional participation in the decline.
Material / Earnings2026-09-15-4.3%
Insmed Incorporated (INSM) moved -4.32% from $125.34 to $119.92 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-09-14-3.2%
Insmed Incorporated (INSM) moved -3.24% from $129.50 to $125.30 on 2026-09-14. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume traded near its 5-day average, suggesting the decline occurred without unusual trading activity.
Material / Earnings2026-09-09+3.1%
Insmed Incorporated (INSM) moved +3.87% from $124.00 to $128.80 on September 9, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.6× the 5-day average, indicating modestly elevated trading interest.
Material / Earnings2026-09-02+4.2%
Insmed Incorporated (INSM) moved +4.56% from $121.11 to $126.63 on 2026-09-02. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move was not driven by unusual trading activity.
Material / Earnings2026-08-31+2.8%
Insmed Incorporated (INSM) moved +2.65% from $118.68 to $121.82 on 2026-08-31. We checked news, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, indicating modestly elevated trading interest.
Upcoming catalysts & outlook
Next earnings
2026-10-29 (est.)
in 28 days
10-Q Filing (est.)
2026-11-05
Medium impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Medium
from change events
Frequently asked questions about INSM
Why did Insmed Incorporated (INSM) stock move?
INSM fell 4.9% to $108.59. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did INSM stock fall?
INSM lost 4.86% ($5.55) versus the prior close of $114.14, last trading at $108.59 on 0.9× average volume.
When is Insmed Incorporated's next earnings date?
INSM's next earnings report is estimated for 2026-10-29 — about 28 days away.
What is the analyst price target for INSM?
The consensus analyst price target for INSM is $197.00, about 81.4% above the current $108.59. Over the past 90 days, analysts recorded 0 upgrades, 9 maintains, and 0 downgrades.
How BestStocks tracks INSM
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared INSM-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for INSM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 1, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
